Endoscopic submucosal dissection is a key technique for the minimally invasive treatment of early-stage gastric cancer. Offering the advantages of minimal trauma, high safety and the ability to resect tumours intact, it has been incorporated into standard treatment protocols in many countries. This article systematically reviews the clinical value, recent developments and controversies surrounding endoscopic submucosal dissection, drawing on relevant research and clinical guidelines. It compares